Evotec - Research never stops
  • Loading...

Archive



Dec 15, 2010

Ad hoc:Evotec announces metabolic disease alliance with MedImmune

Hamburg, Germany - Evotec AG (Frankfurt Stock Exchange, Prime Standard, ISIN: DE 000 566480 9, WKN 566480) today announced that via its subsidiary Develogen AG it has entered into a license and collaboration agreement with MedImmune (the global bi...

- read more
Aug 12, 2010

Ad hoc:Strong Milestone Income Leads to Profitable First Half for Evotec and Increase in Revenue Guidance for the Fiscal Year 2010

Hamburg, Germany - Evotec AG (Frankfurt Stock Exchange, Prime Standard, ISIN: DE 000 566480 9, WKN 566480) today reported financial results and corporate updates for the first half of 2010.   Group revenues grew significantly by 33% to € 25...

- read more
Jul 14, 2010

Ad hoc: Evotec Strengthens Discovery Alliance Business through Acquisition of DeveloGen

- read more